Estrogen Responsiveness and Control of Normal Human Breast Proliferation

Journal of Mammary Gland Biology and Neoplasia

Volumn 3, Issue 1, 1998, Pages 23-35

  Anderson, Elizabeth ^a   Clarke, Robert B ^a   Howell, Anthony ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Estrogen; Estrogen receptor; Human breast; Proliferation

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR;

BREAST; CELL DIFFERENTIATION; CELL DIVISION; CYTOLOGY; FEMALE; HUMAN; PHYSIOLOGY; REVIEW;

BREAST; CELL DIFFERENTIATION; CELL DIVISION; ESTROGENS; FEMALE; HUMANS; RECEPTORS, ESTROGEN;

EID: 0031597977     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018718117113     Document Type: Article

References (72)

1. M. J. McManus and C. W. Welsch (1984). The effect of estrogen, progesterone, thyroxine and human placental lactogen on DNA synthesis of human breast ductal epithelium maintained in athymic nude mice. Cancer 54:1920-1927.
2. H. Fanger and H. J. Ree (1974). Cyclic changes of human mammary gland epithelium in relation to the menstrual cycle - an ultrastructural study. Cancer 34:574-585.
3. P. M. Vogel, N. G. Georgiade, B. F. Fetter, S. Vogel, and K. S. McCarty, Jr. (1981). The correlation of histologic changes in the human breast with the menstrual cycle. Am. J. Pathol. 104:23-34.
4. T. A. Longacre and S. A. Bartow (1986). A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am. J. Surg. Pathol. 10:382-393.
5. J. E. Ferguson, A. M. Schor, A. Howell, and M. W. J. Ferguson (1990). Tenascin distribution in the normal human breast is altered during the menstrual cycle and in carcinoma. Differentiation 42:199-207.
6. J. E. Ferguson, A. M. Schor, A. Howell, and M. W. J. Ferguson (1992). Changes in the extracellular matrix of the normal human breast during the menstrual cycle. Cell Tissue Res. 268:167-177.
7. S. R. Wellings, H. M. Jensen, and R. G. Marcum (1975). An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J. Natl. Cancer Inst. 55:231-273.
8. J. Taylor-Papadimitriou, M. Stampfer, J. Bartek, A. Lewis, M. Boshell, E. B. Lane, and I. M. Leigh (1987). Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. J. Cell Sci. 94:403-413.
9. J. Taylor-Papadimitriou, R. Millis, J. Burchell, R. Nash, L. Pang, and J. Gilbert (1986). Patterns of reaction of monoclonal antibodies HMFG-1 and 2 with benign breast tissues and breast carcinomas. J. Exp. Pathol. 2:247-260.
10. C. S. Potten, R. J. Watson, G. T. Williams, S. Tickle, S. A. Roberts, M. Harris, and A. Howell (1988). The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Brit. J. Cancer 58:163-170.
11. J. R. W. Masters, J. O. Drife, and J. J. Scarisbrook (1977). Cyclic variation of DNA synthesis in human breast epithelium. J. Natl. Cancer Inst. 58:1263-1265.
12. J. S. Meyer (1977). Cell proliferation in normal human breast ducts, fibroadenomas and other ductal hyperplasia measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones. Hum. Pathol. 8:67-81.
13. T. J. Anderson, D. J. P. Ferguson, and G. M. Raab (1982). Cell turnover in the "resting" human breast: influence of parity, contraceptive pill, age and laterality. Brit. J. Cancer 46:376-382.
14. J. J. Going, T. J. Anderson, S. Battersby, and C. C. A. MacIntyre (1988). Proliferative and secretory activity in human breast tissue during natural and artificial menstrual cycles. Am. J. Pathol. 130:193-204.
15. H. Olssen, H. Jernstrom, P. Alm, H. Kreipe, C. Ingvar, P. E. Jonssen, and S. Ryden (1996). Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use and reproductive factors. Breast Cancer Res. Treat. 40:187-196.
16. G. Soderqvist, E. Isaksson, B. von Schoultz, K. Carlstrom, E. Tani, and L. Skoog (1997). Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am. J. Obstet. Gynecol. 176:123-128.
17. W. D. Dupont, D. L. Page, F. F. Parl, C. L. Vnencak-Jones, W. D. Plummer, Jr., M. S. Rados, and P. A. Schuyler (1994). Long term risk of breast cancer in women with fibroadenoma. N. Engl. J. Med. 331:10-15.
18. J. C. Sabourin, A. Martin, J. Baruch, J. B. Truc, A. Gompel, and P. Poitout (1994). bcl-2 expression in normal human breast tissue during the menstrual cycle. Int. J. Cancer 59:1-6.
19. A. Ferenczy, G. Bertrand, and M. M. Gelfand (1979). Proliferation kinetics of human endometrium during the normal menstrual cycle. Am. J. Obstet. Gynecol. 133:859-867.
20. J. C. Felix and S. Farahmand (1997). Endometrial glandular proliferation and estrogen receptor content during the normal menstrual cycle. Contraception 55:19-22.
21. G. Williams, E. Anderson, A. Howell, R. Watson, J. Coyne, S. A. Roberts, and C. Potten (1991). Oral contraceptive use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int. J. Cancer 48:206-210.
22. D. Ricketts, L. Turnbull, G. Ryall, R. Bakhshi, N. S. Rawson, J. C. Gazet, C. Nolan, and R. C. Coombes (1991). Estrogen and progesterone receptors in the normal female breast. Cancer Res. 51:1817-1822.
23. G. Soderqvist, B. von Schoultz, E. Tani, and L. Skoog (1993). Estrogen and progesterone receptor content in breast epithelial cells from healthy women during the menstrual cycle. Am. J. Obstet. Gynecol 168:874-879.
24. M. Boyd, R. H. Hildebrandt, and S. A. Bartow (1996). Expression of the estrogen receptor gene in developing and adult human breast. Breast Cancer Res. Treat. 37:243-251.
25. A. Gompel, A. Martin, P. Simon, D. Schoevaert, G. Plu-Bureau, D. Hugol, J. Audouin, E. Leygue, J. B. Truc, and Ph. Poitout (1996). Epidermal growth factor receptor and c-erbB-2 expression in normal breast tissue during the menstrual cycle. Breast Cancer Res. Treat. 38:227-235.
26. T. van Agthoven, M. Timmermans, J. A. Foekens, L. C. Dorssers, and S. C. Henzen-Logmans (1994). Differential expression of estrogen, progesterone and epidermal growth factor receptors in normal, benign and malignant human breast tissues using dual staining immunohistochemistry. Am. J. Pathol. 144:1238-1246.
27. R. W. Rebar and S. S. C. Yen (1979). Endocrine rhythms in gonadotrophins and ovarian steroids with reference to reproductive processes. In D. T. Krieger (ed.), Endocrine Rhythms, Raven Press, New York, p. 259.
28. B. A. Lessey, A. P. Killam, D. A. Metzger, A. F. Haney, G. L. Greene, and K. S. McCarty, Jr. (1988). Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J. Clin. Endocrinol. Metabol. 67:334-340.
29. C. L. Clarke, J. Titley, S. Davies, and M. J. O'Hare (1994). An immunomagnetic separation using superparamagnetic (MACS) beads for large scale purification of human mammary luminal and myoepithelial cells. Epith. Cell. Biol. 3:38-46.
30. R. J. Pauley, H. D. Soule, L. Tait, F. R. Miller, S. R. Wolman, P. J. Dawson, and G. H. Heppner (1993). The MCF10 family of spontaneously immortalised human breast epithelial cell lines: models of neoplastic progression. Eur. J. Cancer Prev. 2 (suppl 3): 67-76.
31. P. S. Rudland, G. E. Ollerhead, and A. M. Platt-Higgins (1991). Morphogenetic behavior of simian virus 40 transformed human mammary epithelial stem cell lines on collagen gels. In Vitro Cell Dev. Biol. 27A: 103-112.
32. C. Y. Kao, C. S. Oakley, C. W. Welsch, and C. C. Chang (1997). Growth requirements and neoplastic transformation of two types of normal human breast epithelial cells derived from reduction mammoplasty. In Vitro Cell Dev. Biol. 33:282-288.
33. J. Bartek, J. Bartkova, N. Kyprianou, E. N. Lalani, Z. Staskova, M. Shearer, S. Chang, and J. Taylor-Papadimitriou (1991). Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of SV40 large tumor antigen with a recombinant retrovirus. Proc. Natl. Acad. Sci. USA 88:3520-3524.
34. V. Band, D. Zajchowski, V. Kulesa, and R. Sager (1990). Human papilloma virus DNAs immortalise normal human mammary epithelial cells and reduce their growth factor requirements. Proc. Natl. Acad. Sci, USA 87:463-467.
35. L. S. Gollahon and J. W. Shay (1996). Immortalization of human mammary epithelial cells transfected with mutant p53 (273his). Oncogene 12:715-725.
36. C. A. Smith, H. J. Bunnage, P. Monaghan, and A. M. Neville (1987). Human breast epithelium in vitro: the re-expression of structural and functional cellular differentiation in long term culture. Cell Tissue Res. 246:433-440.
37. F. Berdichevsky, D. Alford, B. D'Souza, and J. Taylor-Papadimitriou (1994). Branching morphogenesis of human mammary epithelial cells in collagen gels. J. Cell Sci. 107:3557-3568.
38. O. W. Petersen, L. Ronnov-Jessen, A. R. Howlett, and M. J. Bissell (1992). Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl. Acad. Sci. USA 89:9064-9068.
39. J. J. Gomm, R. C. Coope, P. J. Browne, and R. C. Coombes (1997). Separated human breast epithelial and myoepithelial cells have different growth factor requirements in vitro but can reconstitute normal breast lobuloalveolar structures. J. Cell. Physiol. 171:11-19.
40. N. P. Perusinghe, P. Monaghan, M. J. O'Hare, S. Ashley, and B. A. Gusterson (1992). Effects of growth factors on proliferation of basal and luminal epithelial cells in human breast epithelial explants in serum-free culture. In Vitro Cell Dev. Biol. 28A:90-96.
41. B. M. Gabelman and J. T. Emerman (1992). Effects of estrogen, epidermal growth factor and transforming growth factor α on the growth of human breast epithelial cells in primary culture. Exp. Cell Res. 201:113-118.
42. R. Sakthivel, M. Hamdan, J. Yang, R. C. Guzman, and S. Nandi (1993). Effect of TGFα on growth of normal human breast epithelial cells in serum-free primary culture using 3-dimensional collagen gels. Cell Biol. Int. 17:387-397.
43. Q. Y. Liu, B. Niranjan, P. Gomes, J. J. Gomm, D. Davies, R. C. Coombes, and L. Bulawela (1996). Inhibitory effects of activin on the growth and morphogenesis of primary and transformed mammary epithelial cells. Cancer Res. 56:1155-1163.
44. C. Malet, A. Gompel, H. Yaneva, H. Cren, N. Fidji, I Mowszowicz, F. Kuttenn, and P. Mauvais-Jarvis (1991). Estradiol and progesterone receptors in cultured normal human breast epithelial cells and fibroblasts: immunocytochemical studies. J. Clin. Endocrinol. Metabol. 73:8-17.
45. K-S. Kang, I. Morita, A. Cruz, Y. J. Jeon, J. E. Trosko, and C-C. Chang (1997). Expression of estrogen receptors in a normal human breast epithelial cell type with luminal and stem cell characteristics and its neoplastically transformed cell lines. Carcinogenesis 18:251-257.
46. D. A. Zajchowski, R. Sager, and L. Webster (1993). Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-postive, human mammary epithelial cells expressing a recombinant estrogen receptor. Cancer Res. 53:5004-5011.
47. B. K. Lundholt, M. W. Madsen, A. E. Lykkesfeldt, O. W. Petersen, and P. Briand (1996). Characterisation of a nontumorigenic human breast epithelial cell line stably transfected with the human estrogen receptor (ER) cDNA. Mol. Cell. Endocrinol. 119:47-59.
48. M. J. Pilat, J. K. Christman, and S. C. Brooks (1996). Characterization of the estrogen receptor transfected MCF10A breast cell line 139B6. Breast Cancer Res. Treat. 37:253-266.
49. B. A. Gusterson, J. Williams, H. Bunnage, M. J. O'Hare, and J. D. Dubois (1984). Human breast epithelium transplanted into nude mice. Proliferation and milk protein production in response to pregnancy. Virchows Arch. A Pathol. Anat. Histopathol. 404:325-333.
50. L. G. Sheffield and C. W. Welsch (1988). Transplantation of human breast epithelia to mammary-gland-free fat pads of athymic nude mice: influence of mammotrophic hormones on growth of breast epithelia. Int. J. Cancer 41:713-719.
51. J. D. Dubois, M. J. O'Hare, P. Monaghan, J. Bartek, R. Norris, and B. A. Gusterson (1987). Human breast epithelial xenografts: an immunocytochemical and ultrastructural study of differentiation and lactogenic response. Differentiation 35:72-82.
52. N. K. Popnikolov, J. Yang, R. C. Guzman, and S. Nandi (1995). Reconstituted human normal breast in nude mice using collagen gel or Matrigel. Cell Biol. Int. 19:539-546.
53. I. J. Laidlaw, R. B. Clarke, A. Howell, A. W. M. C. Owen, C. S. Potten, and E. Anderson (1995). Proliferation of normal human breast tissue implanted in athymic nude mice is stimu-lated by estrogen and not progesterone. Endocrinology 136:164-171.
54. R. B. Clarke, A. Howell, and E. Anderson (1997). Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice: analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression. Breast Cancer Res. Treat. 45:121-133.
55. J. H. H. Thijssen, M. A. Blankenstein, J. Daroszewski, and A. Milewicz (1990). Steroids in normal and neoplastic breast tissues. Ann. N.Y. Acad. Sci. 595:222-226.
56. N. L. Weigel (1996). Steroid hormone receptors and their regulation by phosphorylation. Biochem. J. 319:657-667.
57. K. B. Horwitz, T. A. Jackson, D. L. Rain, J. K. Richer, G. S. Takimoto, and L. Tung (1996). Nuclear receptor coactivators and corepressors. Mol. Endocrinol. 10:1167-1177.
58. E. Anderson, R. B. Clarke, and A. Howell (1997). Changes in the normal human breast throughout the menstrual cycle: relevance to carcinogenesis. Endocrine-Related Cancer, 4:23-33.
59. P. Rostagno, C. Caldani, and B. Lahlou (1996). Cell cycle expression of steroid receptors determined by image analysis on human breast cancer cell line: A hypothesis on the effects of antiestrogens. Breast Cancer Res. Treat 37:77-87.
60. J. Gerdes, H. Lemke, H. Baisch, H. H. Wacker, U. Schwab, and H. Stein (1984). Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 133:1710-1715.
61. C. S. Potten and R. J. Morris (1988). Epithelial stem cells in vivo. J. Cell Sci. Suppl. 10:45-62.
62. R. Clarke, R. B. Dickson, and M. E. Lippman (1992). Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions. Crit. Rev. Oncol. Hematol. 12:1-23.
63. C. Knabbe, M. E. Lippman, L. M. Wakefield, K. C. Flanders, A. Kasid, R. Derynck, and R. B. Dickson (1987). Evidence that transforming growth factor β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417-428.
64. F. Kodama, G. L. Green, and S. E. Salmon (1985). Relation of estrogen receptor expression to clonal growth and antiestrogen effects on human breast cancer cells. Cancer Res. 45:2720-2724.
65. O. L. Podhajcer, A. I. Bravo, I. Sorin, N. Guman, R. Cerdeiro, and J. Mordoh (1986). Determination of DNA synthesis, estrogen receptors, and carcinoembryonic antigen in isolated cellular subpopulations of human breast cancer. Cancer 58:720-729.
66. S. E. Bates, E. M. Valverius, B. W. Ennis, D. A. Bronzert, J. P. Sheridan, M. R. Stampfer, J. Mendelsohn, M. E. Lippman, and R. B. Dickson (1990). Expression of the transforming growth factorα/epidermal growth factor receptor pathway in normal human breast epithelial cells, Endocrinology 126:596-607.
67. P. Monaghan, C. L. Clarke, N. P. Perusinghe, M. G. Ormerod, and M. J. O'Hare (1995). Epidermal growth factor receptor expression on human breast luminal and basal cells in vitro. Epithelial Cell Biol. 4:52-62.
68. R. B. Clarke, A. Howell, and E. Anderson (1997). Type I insulin-like growth factor receptor gene expression in normal human breast tissue treated with oestrogen and progesterone. Brit J. Cancer 75:251-257.
69. G. R. Cunha, P. Young, Y. K. Hom, P. S. Cooke, J. A. Taylor, and D. B. Lubahn (1997). Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombination experiments. J. Mam. Gland Biol. Neoplasia. 2:393-402.
70. T. J. A. Key and M. C. Pike (1988). The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur. J. Cancer Clin. Oncol. 24:29-43.
71. M. C. Pike, J. R. Daniels, and D. V. Spicer (1997). A hormonal contraceptive approach to reducing breast and ovarian cancer risk: an update. Endocrine-Related Cancer 4:125-133.
72. J. Russo and I. H. Russo (1997). Role of differentiation in the pathogenesis and prevention of breast cancer. Endocrine-Related Cancer 4:7-21.